Search Within

Lisa Bodei

Formats
  1. Meeting Abstract (69)
  2. Journal Article (62)
  3. Review (34)
  4. Book Section (18)
  5. Editorial (12)
  6. Guidelines (9)
  7. Conference Paper (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Correspondence (1)
Groups
  1. Molecular Imaging and Therapy Service (210)
  2. Radiology, Department of (210)
  3. Sloan Kettering Institute Postdocs (210)
  4. Center for Pancreatic Cancer Research (35)
  5. Department of Medicine (33)
  6. Solid Tumor Oncology Division (31)

More Groups

People
  1. Heiko Schoder (20)
  2. Jason Lewis (18)
  3. Diane Reidy (17)
  4. Joseph O'Donoghue (13)
  5. Simone Krebs (11)
  6. Michael Morris (10)

More People

Years
  1. 2025 (7)
  2. 2024 (15)
  3. 2023 (26)
  4. 2022 (16)
  5. 2021 (27)
  6. 2020 (31)

More Years

Publications
  1. Journal of Nuclear Medicine (36)
  2. Neuroendocrinology (32)
  3. European Journal of Nuclear Medicine and Molecular Imaging (26)
  4. Pancreas (16)
  5. Journal of Clinical Oncology (15)
  6. Radiopharmaceutical Therapy (9)

More Publications

Publishers
  1. Springer (48)
  2. Society of Nuclear Medicine (36)
  3. S. Karger AG (32)
  4. Lippincott Williams & Wilkins (22)
  5. American Society of Clinical Oncology (15)
  6. Elsevier Inc. (11)

More Publishers

Results (210)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The clinical utility of blood neuroendocrine gene transcript measurement in defining surgical resection and residual disease in bronchopulmonary neuroendocrine tumors
    Meeting Abstract

    Filosso, P. L.; Kidd, M.; Roffinella, M.; Chung, K. M.; Lewczuk, A.; Kolasinska-Cwikla, A.; Cwikla, J.; Malczewska, A.; Tesselaar, M.; Kos-Kudla, B.; more...
    Pancreas (2018)

    Fulltext@MSK | Save
  • Chromogranin A is an inadequate circulating biomarker for bronchopulmonary neuroendocrine neoplasia management
    Meeting Abstract

    Malczewska, A.; Kidd, M.; Matar, S.; Lewczuk, A.; Kolasinska-Cwikla, A.; Cwikla, J.; Bodei, L.; Kos-Kudla, B.; Modlin, I.
    Pancreas (2018)

    Fulltext@MSK | Save
  • Blood neuroendocrine transcript analysis for the diagnosis and clinical status assessment of bronchopulmonary neuroendocrine tumors
    Meeting Abstract

    Modlin, I.; Kidd, M.; Lewczuk, A.; Chung, K. M.; Kolasinska-Cwikla, A.; Cwikla, J.; Tesselaar, M.; Malczewska, A.; Kos-Kudla, B.; Bodei, L.; more...
    Pancreas (2018)

    Fulltext@MSK | Save
  • Phase 1/2 open-label trial to assess the safety and preliminary efficacy of (177)Lu-OPS201 as peptide receptor radionuclide therapy in patients with somatostatin receptor-positive, progressive neuroendocrine tumors
    Meeting Abstract

    Nicolas, G.; Bodei, L.; Baum, R.; Herrmann, K.; Lassmann, M.; Hicks, R.; Navalkissoor, S.; Haug, A.; Oberwittler, H.; Wang, T.; more...
    Pancreas (2018)

    Fulltext@MSK | Save
  • Theranostic trial of well differentiated neuroendocrine tumors (NETs) with 68Ga-OPS201 and 177Lu-OPS201
    Meeting Abstract

    Reidy-Lagunes, D.; Pandit-Taskar, N.; Krebs, S.; O'Donoghue, J.; Raj, N. P.; Cruz, E.; Pham, H.; Lashley, A.; Bodei, L.; Weber, W.
    Pancreas (2018)

    Fulltext@MSK | Save
  • Clinical use of Lanreotide AG as initial therapy in patients with advanced, non-resectable well (G1) and moderate (G2) differentiated pancreatic neuroendocrine neoplasms (p-NEN)
    Meeting Abstract

    Cwikla, J.; Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Palucki, J.; Roszkowska-Purska, K.; Kidd, M.; Bodei, L.; Modlin, I.
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • Efficacy of Octreotide LAR in treatment of naive patients with advanced, non-resectable well and moderate differentiated pancreatic neuroendocrine neoplasms (p-NENs)
    Meeting Abstract

    Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Bednarczuk, T.; Palucki, J.; Roszkowska-Purska, K.; Cichocki, A.; Dobkowski, P.; Kidd, M.; Bodei, L.; Modlin, I.; more...
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • Predicting response to PRRT: Development and validation of a blood-based predictive biomarker
    Meeting Abstract

    Bodei, L.; Kidd, M.; Van der Zwan, W.; Singh, A.; Severi, S.; Drozdov, I.; Cwikla, J.; Baum, R. P.; Paganelli, G.; Kwekkeboom, D.; more...
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • PRRT in hindgut and cancer of unknown primary NEN
    Meeting Abstract

    Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Cichocki, A.; Roszkowska-Purska, K.; Dobkowski, P.; Bodei, L.; Cwikla, J.
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • Value of somatostatin receptor scintigraphy (SRS) in patients with appendiceal neuroendocrine neoplasms (ANEN) based on clinical follow-up and results of NETest
    Meeting Abstract

    Konsek, S.; Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Kidd, M.; Buscombe, J. R.; Bodei, L.; Cichocki, A.; Cwikla, J.; Modlin, I.
    Neuroendocrinology (2018)

    Fulltext@MSK | Save